There are 383 resources available
Discussion
Session: More targets, more drugs, more choices, more conflicts
Resources:
Webcast
Introduction and first vote
Presenter: Kersti Oselin
Session: Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
Resources:
Webcast
Radiotherapy perspective for resectable stage III non-small cell lung cancer in the era of immunotherapy
Presenter: Corinne Faivre-Finn
Session: Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
Resources:
Slides
Webcast
RET-fused NSCLC: State of the art treatment of advanced disease, including sanctuary sites
Presenter: Marina Garassino
Session: ESMO Colloquium supported by Eli Lilly and Co. - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Kersti Oselin
Session: Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
Resources:
Webcast
Closing remarks & live Q&A
Presenter: Arnaud Scherpereel
Session: Bristol Myers Squibb - Breaking barriers in thoracic cancers: The expanding possibilities for patients with I-O treatment
Resources:
Webcast
Q&A
Session: New insights in the treatment of geriatric patients
Resources:
Webcast
Update on the Staging Project for the 9th edition of the TNM staging system of thymic tumors
Presenter: Enrico Ruffini
Session: Thymic tumours
Resources:
Slides
Webcast
Early-stage tumors: What is the optimal surgical management in 2022?
Presenter: Vincent Fang
Session: Thymic tumours
Resources:
Slides
Webcast
Locally advanced tumors: The key word is multidisciplinarity
Presenter: Andreas Rimner
Session: Thymic tumours
Resources:
Slides
Webcast